Customer Stories

Bridging Worlds: Translating Complex Technology into Biological Insights

Written by A/Prof Andrew Webb, Ph.D | Mar 28, 2025 4:56:54 AM

Above: The University of British Columbia (UBC) Proteomics Core Facility team. Renata Moravcova, Jason Rogalski and Jeanne Yuan (left to right)

 

Jason Rogalski, the Manager of the Proteomics Core Facility at the University of British Columbia (UBC), stands at a unique crossroads in modern science. His daily work involves bridging two highly specialized worlds—cutting-edge mass spectrometry technology and intricate biological research questions. It’s a demanding role that requires both deep technical mastery and the ability to communicate complex insights clearly and effectively to researchers who may not have expertise in mass spectrometry or bioinformatics.

In a world where scientific instruments often outpace widespread adoption, Jason has cultivated an approach that ensures technology remains accessible and impactful. His team at UBC is uniquely equipped with world-class mass spectrometry instruments, enabling them to conduct sophisticated analyses—from identifying proteins in simple gel bands to comprehensive, large-scale clinical studies. Translating the power and limitations of those techniques to non-proteomics experts is the next step.

Jason’s challenge is not just about running samples through advanced equipment. It’s about making sure the data produced translates meaningfully into real-world biological insights for researchers who may not be bioinformatics experts themselves. Historically, Jason noticed a significant gap—researchers would receive extensive data outputs but struggle to leverage the information effectively. This led to a need for extensive bioinformatic support or, more frequently, ineffective or incomplete data analysis, often reaching incorrect conclusions, or leaving very good information on the table.

"Five years ago, researchers would get a spreadsheet of thousands of protein measurements and feel overwhelmed," Jason explains. "Now, thanks to Mass Dynamics, they get clear visualizations and insights they can easily interpret and act on."

Using the Mass Dynamics platform, Jason not only improves the accessibility and clarity of proteomics data but has transformed the way his collaborators feel about their research. From being overwhelmed by complex spreadsheets to experiencing genuine excitement when exploring their results, researchers now feel empowered and confident. With clear visualizations and intuitive insights at their fingertips, Jason and his collaborators can spend more time uncovering meaningful biological insights with much more satisfaction that a big, expensive, time consuming ‘omics study was a completed package that, at the end of the day, was worth it.

His enthusiasm is palpable when describing recent advancements in thermal proteome profiling—an innovative method allowing researchers to observe protein stability under different temperatures, effectively highlighting protein-drug interactions. 

“What used to require complex interpretations is now straightforward. Researchers can immediately see meaningful differences, empowering them to uncover biological stories that were previously hidden.”

Beyond his technical expertise, Jason’s role involves guiding scientists toward enhanced experimental designs, urging them to pursue greater replication and more robust methods. This subtle yet significant shift produces higher-quality data, richer insights, and, ultimately, stronger research outcomes.

Through this collaborative approach, Jason has also transformed the daily experience of his collaborators. Scientists who once felt overwhelmed by complex datasets now find renewed satisfaction, clarity, and empowerment in their projects. By bridging technical complexity and practical usability, Jason demonstrates how proteomics can evolve to meet the realities of modern biological research. Many researchers that he works with are genuinely surprised by the depth and coverage of the datasets, as well as the many different dimensions of an experiment that can be explored from a single dataset. For the price of a few western blots, one can get thousands of proteins quantified in many different conditions; then with analysis tools like Mass Dynamics, his collaborators can now probe their data in many different ways, digging out many more biological stories than they had originally been looking for.

The real-world effects of Jason’s efforts are significant. His ability to connect clinicians, researchers, and biotech startups through his unique blend of technical mastery and approachable communication has transformed the way scientists around him engage with proteomics. By bridging researchers who possess diverse skillsets, Jason creates outcomes that are more exponential than additive—unlocking potential far beyond what each could achieve alone. This synergy has made proteomics a more accessible, impactful, and integrated part of biological discovery and clinical application in Vancouver.

Jason’s commitment to making complex science comprehensible and actionable embodies the transformative potential of proteomics, shaping a future where technology and biology seamlessly combine to enhance human health and scientific understanding.

At Mass Dynamics, our mission is to remove the barriers between technology and scientific understanding by fostering effective cross-disciplinary collaboration. By enabling researchers like Jason and his collaborators to seamlessly explore, interpret, and leverage proteomics data, we’re helping to create a future where complex science becomes not only manageable but deeply rewarding—fueling discoveries that can genuinely transform lives.

 

--------------------------------------

This Customer Story post was produced by Assoc. Prof. Andrew Webb using a combination of original thoughts, alongside an internal presentation given by Dr Jason Rogalski. Final compilation was completed with assistance from ChatGPT. Any errors or omissions are unintentional, and the content is provided for informational purposes only. The views, thoughts, and opinions expressed in this text belong solely to the author, and not necessarily to the author's employers, organization, committees or other group or individual